Literature DB >> 9714773

Bcl-2 family proteins and mitochondria.

J C Reed1, J M Jurgensmeier, S Matsuyama.   

Abstract

The Bcl-2 family of proteins plays a pivotal role in regulating cell life and death. Many of these proteins reside in the outer mitochondrial membrane, oriented towards the cytosol. Cytoprotective Bcl-2 family proteins such as Bcl-2 and Bcl-XL prevent mitochondrial permeability transition pore opening and release of apoptogenic proteins from mitochondria under many circumstances that would otherwise result in either apoptosis or necrosis. In contrast, some pro-apoptotic members of this family such as Bax can induce these destructive changes in mitochondria in both mammalian cells and when expressed exogenously in yeast. The mechanisms by which Bcl-2 family proteins control cell life and death remain elusive, but may include both the ability to form ion channels or pores in membranes and physical interactions with a variety of proteins implicated in apoptosis regulation.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9714773     DOI: 10.1016/s0005-2728(98)00108-x

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  71 in total

1.  Role of oxidative phosphorylation in Bax toxicity.

Authors:  M H Harris; M G Vander Heiden; S J Kron; C B Thompson
Journal:  Mol Cell Biol       Date:  2000-05       Impact factor: 4.272

2.  Bax oligomerization in mitochondrial membranes requires tBid (caspase-8-cleaved Bid) and a mitochondrial protein.

Authors:  Xavier Roucou; Sylvie Montessuit; Bruno Antonsson; Jean-Claude Martinou
Journal:  Biochem J       Date:  2002-12-15       Impact factor: 3.857

Review 3.  Insights into the mitochondrial signaling pathway: what lessons for chemotherapy?

Authors:  Catherine Brenner; Morgane Le Bras; Guido Kroemer
Journal:  J Clin Immunol       Date:  2003-03       Impact factor: 8.317

4.  Myrtenal attenuates diethylnitrosamine-induced hepatocellular carcinoma in rats by stabilizing intrinsic antioxidants and modulating apoptotic and anti-apoptotic cascades.

Authors:  Lingaiah Hari Babu; Srinivasan Perumal; Maruthaiveeran Periyasamy Balasubramanian
Journal:  Cell Oncol (Dordr)       Date:  2012-06-22       Impact factor: 6.730

5.  Structure of M11L: A myxoma virus structural homolog of the apoptosis inhibitor, Bcl-2.

Authors:  Andrew E Douglas; Kevin D Corbett; James M Berger; Grant McFadden; Tracy M Handel
Journal:  Protein Sci       Date:  2007-04       Impact factor: 6.725

6.  Early regional response of apoptotic activity in newborn piglet brain following hypoxia and ischemia.

Authors:  A Pirzadeh; A Mammen; J Kubin; E Reade; H Liu; A Mendoza; W J Greeley; D F Wilson; A Pastuszko
Journal:  Neurochem Res       Date:  2010-09-26       Impact factor: 3.996

7.  Resuscitation with 100%, compared with 21%, oxygen following brief, repeated periods of apnea can protect vulnerable neonatal brain regions from apoptotic injury.

Authors:  Alberto Mendoza-Paredes; Huiping Liu; Gregory Schears; Zajfang Yu; Scott D Markowitz; Steven Schultz; Peter Pastuszko; William J Greeley; Vinay Nadkarni; Joanna Kubin; David F Wilson; Anna Pastuszko
Journal:  Resuscitation       Date:  2007-08-31       Impact factor: 5.262

8.  Gene therapy targeting leiomyoma: adenovirus-mediated delivery of dominant-negative estrogen receptor gene shrinks uterine tumors in Eker rat model.

Authors:  Memy H Hassan; Salama A Salama; Dong Zhang; Hossam M M Arafa; Farid M A Hamada; Hala Fouad; Cheryl C Walker; Ayman Al-Hendy
Journal:  Fertil Steril       Date:  2009-01-14       Impact factor: 7.329

9.  BCNU down-regulates anti-apoptotic proteins bcl-xL and Bcl-2 in association with cell death in oligodendroglioma-derived cells.

Authors:  Richard A Lytle; Zhihong Jiang; Xiao Zheng; Keith M Rich
Journal:  J Neurooncol       Date:  2004-07       Impact factor: 4.130

Review 10.  Inhibition of mitochondrial membrane permeability as a putative pharmacological target for cardioprotection.

Authors:  D Morin; R Assaly; S Paradis; A Berdeaux
Journal:  Curr Med Chem       Date:  2009       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.